Results 21 to 30 of about 101,214 (211)

Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure. [PDF]

open access: yesPLoS ONE, 2013
OBJECTIVE: Only a limited proportion of patients needing pharmacological control of portal hypertension are hemodynamic responders to propranolol.
Mercedes Reboredo   +13 more
doaj   +1 more source

Correlation of hepatic artery resistive index with portal pressure and serum nitric oxide levels in patients with extrahepatic portal vein obstruction

open access: yesJournal of Indian Association of Pediatric Surgeons, 2020
Aim: The aim was to study the correlation of hepatic artery resistive index (HARI) with the portal pressure (PP) and its surrogate marker serum nitric oxide (NO) levels and to determine the validity of HARI as noninvasive indirect marker of PP in ...
Abhishek Gupta   +5 more
doaj   +1 more source

Managing liver cirrhotic complications: Overview of esophageal and gastric varices [PDF]

open access: yesClinical and Molecular Hepatology, 2020
Managing liver cirrhosis in clinical practice is still a challenging problem as its progression is associated with serious complications, such as variceal bleeding that may increase mortality.
Cosmas Rinaldi Adithya Lesmana   +2 more
doaj   +1 more source

Long-term results after surgical treatment in patients suffering from chronic pancreatitis with signs of biliary hypertension

open access: yesZaporožskij Medicinskij Žurnal, 2018
The morbidity of chronic pancreatitis (CP) remains at a high level. Over the past thirty years, more than doubled growth in the number of patients with chronic pancreatitis has been noted.
V. I. Pylypchuk
doaj   +1 more source

The Effect of Statin Therapy on Mortality in Adult Patients with Liver Cirrhosis: An Evidence-Based Case Report

open access: yesActa Medica Indonesiana, 2022
Background: Liver cirrhosis causes over one million deaths annually worldwide, but its prognosis varies depending on the presence of complications and decompensating events.
Raksheeth Agarwal, Wismandari Wisnu
doaj   +2 more sources

Imaging Approach to Portal Hypertension

open access: yesJournal of Gastrointestinal and Abdominal Radiology, 2023
Increase in portal venous pressure (termed portal hypertension) is seen in a variety of liver diseases. Imaging tests are useful to detect portal hypertension and identify its cause.
Antony Augustine   +5 more
doaj   +1 more source

Portal Venous Pressure Variation during Hepatectomy: A Prospective Study

open access: yesActa Médica Portuguesa, 2019
Introduction: Excessive portal venous pressure in the liver remnant is an independent factor in the occurrence of posthepatectomy liver failure and small-for-size syndrome. The baseline portal pressure prior to hepatectomy was not considered previously.
Jorge Gomes Carrapita   +8 more
doaj   +1 more source

Hepatic venous pressure gradient: clinical use in chronic liver disease [PDF]

open access: yesClinical and Molecular Hepatology, 2014
Portal hypertension is a severe consequence of chronic liver diseases and is responsible for the main clinical complications of liver cirrhosis. Hepatic venous pressure gradient (HVPG) measurement is the best available method to evaluate the presence and
Ki Tae Suk
doaj   +1 more source

Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats

open access: yesPharmaceutics, 2020
Background: Portal hypertension is characterized by exaggerated activation of the renin-angiotensin-aldosterone axis. Natriuretic peptide system plays a counter-regulatory role, which is modulated by neprilysin.
Shao-Jung Hsu   +6 more
doaj   +1 more source

Blockade of Mas Receptor or Mas-Related G-Protein Coupled Receptor Type D Reduces Portal Pressure in Cirrhotic but Not in Non-cirrhotic Portal Hypertensive Rats

open access: yesFrontiers in Physiology, 2019
Portal hypertension (PHT) resulting from splanchnic vasodilatation is a major cause of morbidity and mortality in patients with cirrhosis. The renin-angiotensin system (RAS) plays an important role in splanchnic vasodilatation in cirrhosis.
Lakmie S. Gunarathne   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy